Join
Live feed
·
INSIDERFilingvia Quantisnow
Reata Pharmaceuticals Inc. logo

SEC Form 4: Meyer Colin John sold $52,518 worth of shares (621 units at $84.57), decreasing direct ownership by 0.73% to 84,606 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RETA (Reata Pharmaceuticals Inc.) and more on Quantisnow.